SAN DIEGO--(BUSINESS WIRE)--ResMed (NYSE: RMD) (ASX: RMD) today introduced AirFit N30, the world’s first tube-down nasal cradle CPAP mask with a front-facing tube – a brand-new option for sleep apnea ...
ResMed RMD has introduced AirFit N30, which is the first tube-down nasal cradle continuous positive airway pressure (“CPAP”) mask, with a front-facing tube. This will present the latest treatment ...
LYON, France, Oct. 25, 2017 /PRNewswire/ -- ResMed (NYSE: RMD) today announced the European release of its AirFit N20 Classic nasal mask for positive airway pressure (PAP) treatment, to give patients ...
ResMed (NYSE: RMD) (ASX: RMD) today introduced AirFit N30, the world’s first tube-down nasal cradle CPAP mask with a front-facing tube – a brand-new option for sleep apnea treatment. This press ...
ResMed is releasing a new nasal cradle CPAP mask that features a front-facing tube that points downward. The AirFit N30 mask is the first of its kind, as similar masks typically have the air tube ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback